Adhera Therapeutics, Inc. (ATRX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 31, 2025, 10:16 AM EDT
Adhera Therapeutics Company Description
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs.
The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes.
The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018.
Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Adhera Therapeutics, Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
Contact Details
Address: 8000 Innovation Parkway Baton Rouge, Delaware 70820 United States | |
| Phone | 919 518 3748 |
| Website | adherathera.com |
Stock Details
| Ticker Symbol | ATRX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US00687E1091 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Andrew Albert Kucharchuk M.B.A. | Vice Chairman, Chief Operating Officer and Chief Business Officer |